As positive as a FDA approval is, the impact is diminished if that is the announcement. At the very least I would expect a high level plan on entering the US market, with assumptions outlining commercial model, partnerships, pricing/ margin and indicative sales and market penetration first 12 months.
Given the potential of the US market the numbers get big very quickly!
